2020 ISPE Pharma 4.0™ Virtual Conference

Pharma 4.0 Business Foundations and Implementation Approaches

Thank You for Making this Virtual Conference a Huge Success!  Attendees access your on demand content now.

Access On Demand Content


Amit Nastik, Head NTO Global Strategy, Operations and Local Markets Manufacturing, Novartis, kicked off the 2020 ISPE Pharma 4.0™ Virtual Conference today with his presentation "A Vision of Pharma 4.0 Operations."

In this clip, Amit shows highlights why data is a key piece of digital and why it is important to deploy the right technology for the right activities.


What Are the Benefits of Assisted Reality?

Watch this clip to hear from Amelia Muñoz Callizo, Site Head of Merck KGaA - Mollet Site, Merck Group, as she highlights benefits and challenges pharma to think big during her presentation “Assisted Reality on the Shop Floor” at the 2020 ISPE Pharma 4.0™ Virtual Conference.


How Do We Bring More Diversity and Inclusion to Life? How Do We Bring Sustainability to Life?

Teresa Rodó, PhD, EVP Global Healthcare Operations, Merck Group, answered these questions during her presentation "Boost and Sustain Performance for Tomorrow" at the 2020 ISPE Pharma 4.0™ Virtual Conference.

Watch this clip to hear her touch on the importance of diversity and sustainability, and how Merck Group is bringing these facets to life in their organization.


Are Digital Therapeutics Really Effective?

Watch this clip from the 2020 ISPE Pharma 4.0™ Virtual Conference to see what Giuseppe Recchia, Co-Founder & CEO, daVinci Digital Therapeutics, had to say during his presentation “Connected Health - World after COVID - Digital Therapeutics.”


The Difference between Cloud Computing & the Internet of Things

Watch Now: In this clip from the 2020 ISPE Pharma 4.0™ Virtual Conference, Aurelio Ravarini, Professor of Digital Transformation Design, LIUC - Università Cattaneo, describes the difference between Cloud Computing and the Internet of Things (IoT).


How Pharma 4.0™ Can Facilitate the Implementation of Ich q12 in the Lifecycle of a Product

Watch Now: Nuha Al-Hafez, Head Of Connected Health, Merck Group, shared her thoughts on how Pharma 4.0™ could facilitate the implementation of ICH Q12 in the lifecycle of a product during the Panel Discussion with Speakers from "Pharma 4.0 & Regulations" Track panel discussion at the at the 2020 ISPE Pharma 4.0™ Virtual Conference.


What Is the Biggest Hurdle in Your Field in Regards to Digitalization?

Christian Wölbeling, Executive Industry Advisor, Körber Pharma, posed this question during the panel Q&A with speakers from the 2020 ISPE Pharma 4.0™ Virtual Conference Track "Pharma 4.0 Vision."

Watch this clip to hear thoughts from david sternasty, Vice President, Corporate Engineering, Eli Lilly and Company, Teresa Rodó, PhD, EVP Global Healthcare Operations, Merck Group, Amit Nastik, Head NTO Global Strategy, Operations and Local Markets Manufacturing, Novartis, and James Thomas, Head of Digital Strategy, Bayer.


2020 Pharma 4.0™ Plant Tour Goodly Innovations

During the 2020 ISPE Pharma 4.0™ Virtual Conference, Goodly Innovations GmbH took us on a tour through the development and the current state of Augmented Reality (AR) in a regulated environment.

In this clip, Goodly Innovations CEO Robert Hoffmeister takes us through the AR change over process.

Receive Notifications

Stay up-to-date on registration, education opportunities, speakers, hotel discounts, exhibitor information, and more by signing up to receive notifications for the 2021 ISPE Pharma 4.0™ and Annex 1 Conference.

Name
Company Type